Home Acta Virologica 2016 Acta Virologica Vol.60, No.2, p.143-150, 2016

Journal info


Quarterly,
Founded: 1957
ISSN 0001-723X
E-ISSN 1336-2305

Published in English

Aims and Scope
Editorial Info

Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Acta Virologica Vol.60, No.2, p.143-150, 2016

Title: Development and application of ELISA for the detection of IgG antibodies to lymphocytic choriomeningitis virus
Author: K. LAPOŠOVÁ, Ľ. LUKÁČIKOVÁ, I. OVEČKOVÁ, S. PASTOREKOVÁ, J. ROSOCHA, D. KUBA, Ľ. BEŇA, J. TOMÁŠKOVÁ

Abstract: Lymphocytic choriomeningitis virus (LCMV) is a neglected human pathogen, which can cause severe illnesses in humans. The most vulnerable are the human foetus and immunosuppressed individuals. Since there is no commercially available enzyme-linked immunosorbent assay (ELISA) for the diagnosis of anti-LCMV antibodies in human sera, we developed a sandwich ELISA method detecting anti-nucleoprotein IgG antibodies, using a specific monoclonal anti-nucleoprotein antibody and cells persistently infected with LCMV strain MX as antigen. In the present study we show standardization of this ELISA protocol, determination of its clinical specificity and sensitivity and its application on 30 clinical samples from multiorgan donors. Comparison of these results to the indirect immunofluorescence antibody test (IFA) demonstrates that ELISA is more sensitive. The developed ELISA assay provides a fast, simple and efficient tool for the clinical detection of anti-nucleoprotein antibodies in human sera.

Keywords: lymphocytic choriomeningitis virus; ELISA; human serum; IgG antibodies
Published online: 06-Jun-2016
Year: 2016, Volume: 60, Issue: 2 Page From: 143, Page To: 150
doi:10.4149/av_2016_02_143


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.